Key result
Higher baseline lateral MAPSE is linked to fewer AF recurrences 6 months post-ablation.
Why the study?
The study aimed to evaluate the role of echocardiographic variables, particularly mitral annular plane systolic excursion (MAPSE), in predicting catheter ablation outcomes in patients with AF.
Does lateral MAPSE predict atrial fibrillation recurrence in patients with paroxysmal and persistent atrial fibrillation undergoing catheter ablation?
Cohort (n=40)
No
Does lateral MAPSE predict atrial fibrillation recurrence in patients with paroxysmal and persistent atrial fibrillation undergoing catheter ablation?
Lateral MAPSE could serve as a simple, non-invasive early echocardiographic predictor of AF recurrence after pulmonary vein isolation.
Lateral MAPSE may aid post-ablation AF risk stratification; leaves open its incremental value and requires validation before clinical use.
Introduction. Catheter ablation (CA) with pulmonary vein isolation (PVI) has become widely used in the past years for the treatment of atrial fibrillation (AF). Mitral annular plane systolic excursion (MAPSE) is the parameter that measures left ventricular longitudinal function, and it appears to be a good early marker of LV dysfunction. It is practically independent of poor image quality. The aim of our study was to analyse the role of echocardiographic variables, especially MAPSE in predicting the outcome of CA in patients with AF. Materials and Methods. We prospectively included 40 patients with paroxysmal and persistent AF that were referred for CA. All patients underwent radiofrequency CA with PVI. Standard transthoracic two-dimensional echocardiography was conducted one day after CA. Demographic data and the patients’ characteristics were noted. The endpoint of our study was to estimate the AF recurrence rate diagnosed by ECG within 6 months of the follow-up period. Results. 40 patients, mainly male (67.5%) with an average age of 61.43 ± 8.96 years were included in our study. The majority of patients had paroxysmal AF prior to ablation (77.5%). The AF recurrence rate was 20% after 6 months of follow-up. Lateral MAPSE in the AF-free group was greater than those who relapsed (1.57 ± 0.24 vs. 1.31 ± 0.25; <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" id="M1"> <a:mi>p</a:mi> <a:mo>=</a:mo> <a:mn>0.012</a:mn> </a:math> ). Patients who remained AF-free after a 6-month follow-up period had a significantly smaller left ventricular volume index (LAVI) than those who relapsed (34.29 ± 6.91 ml/m2 vs. 42.90 ± 8.43 ml/m2; <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" id="M2"> <c:mi>p</c:mi> <c:mo>=</c:mo> <c:mn>0.05</c:mn> </c:math> ). We found a significant reverse relationship between LAVI and MAPSE ( <e:math xmlns:e="http://www.w3.org/1998/Math/MathML" id="M3"> <e:mi>p</e:mi> <e:mo>=</e:mo> <e:mn>0.020</e:mn> </e:math> ). Conclusion. MAPSE and LAVI present risk factors for AF recurrence, specifically reduced MAPSE and larger LAVI, are related to AF recurrence after CA. In the future, MAPSE could play a significant role when predicting the CA outcome in patients with AF.
No takes yet. Share an insight, caveat, or question.
Alatic et al. (2022) conducted a cohort in Atrial Fibrillation (n=40). Lateral Mitral Annular Plane Systolic Excursion (MAPSE) was evaluated on Atrial fibrillation recurrence diagnosed by ECG within 6 months (p=0.012). Higher baseline lateral MAPSE was significantly associated with remaining free from atrial fibrillation at 6 months post-ablation compared to patients who relapsed (1.57 ± 0.24 vs. 1.31 ± 0.25; p=0.012).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: